in vivo-jetPEI®-Gal is a galactose-conjugated in vivo-jetPEI® derivative designed to enhance delivery to cells expressing galactose-specific membrane lectins, such as the asialoglycoprotein receptor (ASGP-R or Gal/GalNAc receptor).
- Suitable for in vivo delivery of any nucleic acid
- Very simple to use: Two-step protocol
- Safe: No inflammatory response triggered
- Protocols tailored for your application by Polyplus-transfection® delivery experts
Since 1st of September 2021 Polyplus-Tranfection changed product part numbers. Products are remaining the same and the change is only related to the product part number. New product part numbers have symbol “New”. For duplicated products with symbol “telephone” please be informed that it’s the same product but with previous part number which we will only offer till the end of stock.
Certyfikaty: Polyplus-transfection® has been an ISO 9001 accredited company since 2002. Since then this certification has been successfully renewed every three years.
Each lot of in vivo-jetPEI®-Gal is validated by DNA (pCMV-Luciferase) delivery into mouse through intravenous injection. The amount of luciferase (ng) per mg of protein is indicated on the Certificate of Analysis for each lot of reagent. Moreover, absence of endotoxin is verified in every lot of in vivo-jetPEI®-Gal.
Informacja o dostawie: 10% glucose solution is included. 0,1 ml of in vivo-jetPEI®-Gal delivery reagent is sufficient to perform up to 20 intravenous injections in mouse with 50 µg of DNA.